Fowler, N. H., Davis, R. E., Rawal, S., Nastoupil, L., Hagemeister, F. B., McLaughlin, P., . . . Neelapu, S. S. (2014). Safety, activity, and immune effects of lenalidomide and rituximab in untreated indolent lymphoma. Lancet Oncol.
Stile di citazione ChicagoFowler, Nathan H., et al. "Safety, Activity, and Immune Effects of Lenalidomide and Rituximab in Untreated Indolent Lymphoma." Lancet Oncol 2014.
Citazione MLAFowler, Nathan H., et al. "Safety, Activity, and Immune Effects of Lenalidomide and Rituximab in Untreated Indolent Lymphoma." Lancet Oncol 2014.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.